Clinical Trial Update: Posaconazole vs Itraconazole in Preventing IFD Post-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update comparing posaconazole to itraconazole for preventing invasive fungal disease after hematopoietic stem cell transplant, spanning Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Disease Post-hematopoietic Stem Cell Transplant

Drugs mentioned

• Itraconazole (Itraconazole)
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Fujian Medical University | Conditions: IFD Post-HSCT | Phase 2, Phase 3 | Status: UNKNOWN